Bivalirudin

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction

Use of Bivalirudin for Anticoagulation in Patients With Extracorporeal Membrane Oxygenation

Bivalirudin With Prolonged Full Dose Infusion Versus Heparin Alone During Emergency PCI

A Study on the Impact of Bivalirudin Usage During PCI for High-risk Plaques on Post-PCI Coronary Microcirculation.

Pharmacokinetics of Bivalirudin for Pediatric Anticoagulation

Bivalirudin with Prolonged Infusion During PCI Versus Heparin After Fibrinolytic Therapy

BivaLirudin versUS Heparin in Extracorporeal Membrane Oxygenation

Comparison of Anticoagulation Prolongation vs. no Anticoagulation in STEMI Patients After Primary PCI

Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO

Bivalirudin Versus Enoxaparin in Critically Ill COVID-19 Patients

Safety and Efficacy of Bivalirudin During Short-term Intervention of Non-infarction Related Artery After PPCI of STEMI

Reduce Bolus Injection of Bivalirudin

Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients

Multi-center Application of Bivalirudin in Left Atrial Appendage Occlusion

Bivalirudin in Late PCI for Oatients With STEMI

Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention.

Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation

Bivalirudin in Elderly Patients With Acute ST-segment Elevation Myocardial Infarction

Bivalirudin Infusion for Ventricular Infarction Limitation